J&J Subsidiary, FDA Warn Against Death, Liver Damage Risk For People Taking Antiretroviral Prezista (Medical News Today)
FDA and Johnson & Johnson subsidiary Tibotec have issued a warning about the risk of liver damage and death for people taking the antiretroviral drug Prezista, the Wall Street Journal reports.In a letter posted on FDA's Web site Wednesday, Tibotec said that it has received reports of liver injury and some deaths since the drug was approved in June 2006 (Wall Street Journal, 3/13).

Abbott Continues Win Streak With Humira Biological Drug (Investor's Business Daily via Yahoo! News)
It's six for six at Abbott Labs. That's six regulatory approvals on six applications for the company's biological drug, Humira.